Innovation

Our Innovation

 

RUBYnanomed innovated in developing an automated, easy-to-use and fully streamlined workflow for liquid biopsy

 

pic 2__

RUBYchip® is complemented with automated sample processing, staining, image acquisition and analysis, ensuring reliability. Low inter-laboratory and fast implementation towards non-invasive and continuous monitoring of patients.

Learn more

Our Projects

Ongoing
BRIGHT EU

BRIGHT EU

EIC Accelerator by European Innovation Council
Know more
Ongoing
BIOCELLPHE

BIOCELLPHE

EU Horizon 2020
Know more
Ongoing
HfPT – Health from Portugal

HfPT – Health from Portugal

European Union-Next Generation UE
Know more
Finished
CTC-OncoDynamics

CTC-OncoDynamics

Caixa Impulse Consolidate by LA CAIXA Foundation
Know more
Finished
PERSIST

PERSIST

EU Horizon 2020
Know more
Finished
BRIGHT PT

BRIGHT PT

AVISO 18 Norte 2020
Know more

Partnerships

Publications

See more
Establishing an Expert Consensus on Key Indicators of the Quality of Life among Breast Cancer Survivors: A Modified Delphi Study

2022

Read more
Discriminating Epithelial to Mesenchymal Transition Phenotypes in Circulating Tumor Cells Isolated from Advanced Gastrointestinal Cancer Patients

2023

Read more
HER2 Expression in Circulating Tumour Cells Isolated from Metastatic Breast Cancer Patients Using a Size-Based Microfluidic Device

2023

Read more
The Significance of Circulating Tumour Cells in the Clinic

2023

Read more
Exploring sialyl-Tn expression in microfluidic-isolated circulating tumour cells: A novel biomarker and an analytical tool for precision oncology applications

2020

Read more
Sialyl-Tn identifies muscle-invasive bladder cancer basal and luminal subtypes facing decreased survival, being expressed by circulating tumor cells and metastases

2023

Read more
Click here